MedTrace Logo

The Extended Study of Prevalence of Infection in Intensive Care IV

NCT07309549 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-12-30

No results posted yet for this study

Summary

The goal of this observational study is to learn how common infections are in intensive care units (ICUs) around the world and how they are treated. The study will look at all adults in the ICU during a single 24-hour period. The main questions it aims to answer are:

* What types of infections and antibiotic-resistant bacteria are most common in ICUs worldwide?
* How do resistance patterns affect how participants are treated and how they recover?

How are antibiotics used in ICUs, and how do hospitals practice antibiotic stewardship?

* What organ support treatments do participants with infections receive?
* What are the outcomes of participants with severe infections, including survival at hospital discharge (up to 60 days)?

Researchers will compare ICUs across regions and income levels to see how infection patterns, treatments, and outcomes differ around the world.

Participants will:

* Be counted if they are present in the ICU at any time during the study day.
* Have information collected from their medical record about their health, the infection they may have, treatments they receive, and their outcome at ICU and hospital discharge (up to 60 days).

Because this is an observational study, participants will not receive any new treatments as part of the study.

Conditions

Sponsors & Collaborators

  • St. James's Hospital, Ireland

    collaborator OTHER

  • Universidad de la Sabana

    lead OTHER

Principal Investigators

  • Ignacio-Martin Loeches, MD, PhD, FJFICMI · St James' Hospital. Dublin, Ireland

  • Luis Felipe Reyes, MD, MSc, PhD · Universidad de La Sabana. Chia, Colombia

  • Jean-Louis Vincent, MD, PhD · Erasme University Hospital. Brussels, Belgium

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-31
Primary Completion
2026-03-31
Completion
2026-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07309549 on ClinicalTrials.gov